“…Importantly, increasing evidence suggests that the gut microbiota and its metabolites are involved in the development and progression of several types of cancer by influencing inflammation, DNA damage, and apoptosis [63]. Several studies have identified that the decrease of several potentially beneficial bacterial species (including Lactobacillus, Bifidobacterium, Oscillibacter, Ruminiclostridium 9, and Dubosiella), and the increase of some adverse bacterial species (including Enterococcus, Enterotoxigenic bacteroides fragilis, Streptococcus, Helicobacter, Fusobacterium nucleatum, Escherichia-Shigella, Klebsiella and Akkermansia), which are closely correlated with an increased risk of CRC [11,13,17,[64][65][66]. The data from our study showed that AOM/DSS stimulus inevitably disturbed the balance of intestinal microbiota, as shown by a dramatic decrease in the abundance of dominant microbiota Lactobacillus and Dubosiella, and an increase in the abundance of harmful bacteria Bacteroides, Escherichia-Shigella, and Akkermansia.…”